CO6541535A2 - Nuevos derivados de azabiciclicos [3.1.0] hex-2- ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen - Google Patents
Nuevos derivados de azabiciclicos [3.1.0] hex-2- ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienenInfo
- Publication number
- CO6541535A2 CO6541535A2 CO12095636A CO12095636A CO6541535A2 CO 6541535 A2 CO6541535 A2 CO 6541535A2 CO 12095636 A CO12095636 A CO 12095636A CO 12095636 A CO12095636 A CO 12095636A CO 6541535 A2 CO6541535 A2 CO 6541535A2
- Authority
- CO
- Colombia
- Prior art keywords
- azabiciclicos
- ilo
- hex
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Compuestos de fórmula (I)en la que: ALK representa una cadena alquileno, W representa un grupo en el que R y R son tales como se han definido en la descripción. Medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0905953A FR2953521B1 (fr) | 2009-12-09 | 2009-12-09 | Nouveaux derives azabicyclo[3.1.0]hex-2-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6541535A2 true CO6541535A2 (es) | 2012-10-16 |
Family
ID=42711699
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO12095636A CO6541535A2 (es) | 2009-12-09 | 2012-06-06 | Nuevos derivados de azabiciclicos [3.1.0] hex-2- ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen |
Country Status (31)
Country | Link |
---|---|
US (1) | US20120283245A1 (es) |
EP (1) | EP2509947A1 (es) |
JP (1) | JP2013513589A (es) |
KR (1) | KR20120102763A (es) |
CN (1) | CN102652127A (es) |
AP (1) | AP2012006352A0 (es) |
AR (1) | AR079265A1 (es) |
AU (1) | AU2010329762B2 (es) |
BR (1) | BR112012013666A2 (es) |
CA (1) | CA2782469C (es) |
CL (1) | CL2012001479A1 (es) |
CO (1) | CO6541535A2 (es) |
CR (1) | CR20120286A (es) |
CU (1) | CU20120091A7 (es) |
EA (1) | EA201200849A1 (es) |
EC (1) | ECSP12011950A (es) |
FR (1) | FR2953521B1 (es) |
GE (1) | GEP20156227B (es) |
IN (1) | IN2012DN04966A (es) |
MA (1) | MA33882B1 (es) |
MX (1) | MX2012006578A (es) |
NI (1) | NI201200099A (es) |
PE (1) | PE20121475A1 (es) |
SA (1) | SA110320011B1 (es) |
SG (1) | SG181082A1 (es) |
TN (1) | TN2012000267A1 (es) |
TW (1) | TW201200499A (es) |
UA (1) | UA102950C2 (es) |
UY (1) | UY33072A (es) |
WO (1) | WO2011070253A1 (es) |
ZA (1) | ZA201203943B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015032966A1 (en) * | 2013-09-09 | 2015-03-12 | Sanofi | An h3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2866647B1 (fr) * | 2004-02-20 | 2006-10-27 | Servier Lab | Nouveaux derives azabicycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
KR20080076987A (ko) * | 2005-11-30 | 2008-08-20 | 에프. 호프만-라 로슈 아게 | 5-치환된 인돌-2-카복스아미드 유도체 |
-
2009
- 2009-12-09 FR FR0905953A patent/FR2953521B1/fr not_active Expired - Fee Related
-
2010
- 2010-12-01 UY UY0001033072A patent/UY33072A/es unknown
- 2010-12-03 TW TW099142190A patent/TW201200499A/zh unknown
- 2010-12-06 AR ARP100104484A patent/AR079265A1/es not_active Application Discontinuation
- 2010-12-07 SA SA110320011A patent/SA110320011B1/ar unknown
- 2010-12-08 BR BR112012013666A patent/BR112012013666A2/pt not_active IP Right Cessation
- 2010-12-08 UA UAA201208178A patent/UA102950C2/ru unknown
- 2010-12-08 JP JP2012542591A patent/JP2013513589A/ja not_active Ceased
- 2010-12-08 WO PCT/FR2010/000823 patent/WO2011070253A1/fr active Application Filing
- 2010-12-08 GE GEAP201012774A patent/GEP20156227B/en unknown
- 2010-12-08 IN IN4966DEN2012 patent/IN2012DN04966A/en unknown
- 2010-12-08 MX MX2012006578A patent/MX2012006578A/es active IP Right Grant
- 2010-12-08 CA CA2782469A patent/CA2782469C/fr not_active Expired - Fee Related
- 2010-12-08 KR KR1020127017843A patent/KR20120102763A/ko not_active Application Discontinuation
- 2010-12-08 MA MA34932A patent/MA33882B1/fr unknown
- 2010-12-08 AU AU2010329762A patent/AU2010329762B2/en not_active Ceased
- 2010-12-08 PE PE2012000722A patent/PE20121475A1/es not_active Application Discontinuation
- 2010-12-08 AP AP2012006352A patent/AP2012006352A0/xx unknown
- 2010-12-08 EA EA201200849A patent/EA201200849A1/ru unknown
- 2010-12-08 SG SG2012038931A patent/SG181082A1/en unknown
- 2010-12-08 EP EP10799080A patent/EP2509947A1/fr not_active Withdrawn
- 2010-12-08 CN CN2010800559947A patent/CN102652127A/zh active Pending
- 2010-12-08 US US13/514,796 patent/US20120283245A1/en not_active Abandoned
-
2012
- 2012-05-28 TN TNP2012000267A patent/TN2012000267A1/fr unknown
- 2012-05-29 CR CR20120286A patent/CR20120286A/es unknown
- 2012-05-30 ZA ZA2012/03943A patent/ZA201203943B/en unknown
- 2012-06-05 EC ECSP12011950 patent/ECSP12011950A/es unknown
- 2012-06-06 CO CO12095636A patent/CO6541535A2/es unknown
- 2012-06-06 CL CL2012001479A patent/CL2012001479A1/es unknown
- 2012-06-07 CU CU20120091A patent/CU20120091A7/es unknown
- 2012-06-07 NI NI201200099A patent/NI201200099A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CU20140089A7 (es) | Nuevos derivados de indolizina, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CU20130082A7 (es) | 1,2 oxazol-8-azabiciclo[3,2,1]octano 8 il como moduladores de fxr | |
CU20110204A7 (es) | Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750 | |
CU20140081A7 (es) | Nuevos derivados de pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
UY33201A (es) | Compuestos de pirazol como antagonistas de crth2. | |
ECSP11011340A (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
DOP2011000382A (es) | Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas | |
SV2009003199A (es) | Nuevos derivados de diosmetina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
NI200900147A (es) | Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen. | |
HN2010001537A (es) | Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY33073A (es) | Nuevos derivados del tipo hexahidrociclopenta [ b]pirrol, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
UY31857A1 (es) | Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CO6541535A2 (es) | Nuevos derivados de azabiciclicos [3.1.0] hex-2- ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
AR061740A1 (es) | Nuevos derivados naftalenicos, su procedimiento de praparacion y las composiciones farmaceuticas que los contienen | |
UY33074A (es) | Nuevos derivados de azabiciclo[3.2.0]hept-6-ilo, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
UY33046A (es) | Nuevos derivados de azabiciclo[3.2.0]hept-3-ilo, su procedimiento de prepración y las composiciones farmacéuticas que los contienen | |
GT201300067A (es) | Nuevos derivados dihidrobenzoxatiazepinas. su procedimiento de preparacion y las composiciones farmaceuticas que los | |
ECSP10010292A (es) | Nuevos derivados de ácido 2-mercaptociclopentanocarboxílico, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CU20090105A7 (es) | Nuevos derivados azabicíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
CR20120109A (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
AR061741A1 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
UY32154A (es) | Derivados de isoquinolinona, procesos para su preparacion, composiciones farmaceuticas que los contiene y su uso en terapia | |
CU20090134A7 (es) | Nuevos derivados tricíclicos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
UY30879A1 (es) | Nuevos derivados triciclicos, su procedimiento de preparacion y las composiciones farmacéuticas que los contienen. |